Action 7325 IRRC CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues IRRC Corporation

Actions

7325

JP3105230001

Marché Fermé - Japan Exchange
Autres places de cotation
 08:00:00 01/05/2024 		Varia. 5j. Varia. 1 janv.
724 JPY -0,28 % Graphique intraday de IRRC Corporation -0,96 % +12,07 %
2023 IRRC Corporation (TSE:7325) a finalisé l'acquisition d'une participation de 80,9% dans Life Assist Co., Ltd. auprès d'Orix Life Insurance Corporation. CI
2023 IRRC Corporation (TSE:7325) annonce un rachat d'actions pour 200.000 actions, représentant 2,38% pour 160 millions ¥. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Tranche Update on IRRC Corporation's Equity Buyback Plan announced on August 18, 2023.
IRRC Corporation's Equity Buyback announced on August 18, 2023, has closed with 200,000 shares, representing 2.39% for ¥140.90 million.
Tranche Update on IRRC Corporation's Equity Buyback Plan announced on August 18, 2023.
Henlius Biotech, Inc. - Results from Four Phase 1/2 Clinical Trials of Henlius Innovative Products Released at 2023 ESMO Asia
Tranche Update on IRRC Corporation's Equity Buyback Plan announced on August 18, 2023.
IRRC Corporation completed the acquisition of 80.9% stake in Life Assist Co., Ltd. from Orix Life Insurance Corporation.
IRRC Corporation announces an Equity Buyback for 200,000 shares, for ¥160 million.
IRRC Corporation authorizes a Buyback Plan.
Tranche Update on IRRC Corporation's Equity Buyback Plan announced on February 14, 2023.
IRRC Corporation's Equity Buyback announced on February 14, 2023, has closed with 300,300 shares, representing 3.48% for ¥228.63 million.
IRRC Corporation signed a basic agreement to acquire a 80.9% stake in Life Assist Co., Ltd. from Orix Life Insurance Corporation for approximately ¥400 million.
Tranche Update on IRRC Corporation's Equity Buyback Plan announced on February 14, 2023.
IRRC Corporation Reports Earnings Results for the Nine Months Ended March 31, 2023
Tranche Update on IRRC Corporation's Equity Buyback Plan announced on February 14, 2023.
CStone Announces Publication of GEMSTONE-201 Study Results for Sugemalimab Monotherapy in the Treatment of Relapsed, Refractory Extranodal NK/T-Cell Lymphoma in Journal of Clinical Oncology
IRRC Corporation announces an Equity Buyback for 500,000 shares, representing 5.74% for ¥400 million.
IRRC Corporation authorizes a Buyback Plan.
Kyowa Kirin and MEI Pharma Announce Topline Data from the Phase 2 MIRAGE Study Evaluating Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma in Japan
CStone presents clinical results of sugemalimab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma via an oral abstract session at ASCO 2022
IRRC : Pennsylvania Takes Next Step Toward Cap-and-Trade Amid Resistance
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 7325
  4. Actualités IRRC Corporation
  5. Autres langues